The clonidine micropellet, shown next to a dime for size comparison, is implanted in a patient's lower back to combat sciatica pain for up to one year. (Photo courtesy of Sollis Corp.)

WVU first site to launch clinical trial utilizing non-opioid micropellet implant for chronic pain

As part of an ongoing commitment to battle opioid addiction, the Rockefeller Neuroscience Institute at West Virginia University today marked a major milestone, enrolling the first patient in a randomized clinical trial that will test the effectiveness of an injectable non-opioid, non-steroid micropellet to treat sciatica.

The phase III clinical trial utilizes a clonidine micropellet, which is half the size of a grain of rice and is placed in a patient’s lower back to combat sciatica pain for up to one year. The procedure was successfully completed this afternoon.

“Innovative technologies that act directly at a target location like this micropellet are crucial to reducing the need for systemic medications and opioids for chronic pain,” Ali Rezai, MD, executive chair of the Rockefeller Neuroscience Institute, said. “Our hope is that we can look back on this day and say we made a significant advance in the ongoing efforts to treat chronic pain and combat the opioid crisis.”

Rezai is not directly involved in the trial as he serves as a scientific advisor to Sollis Therapeutics, the Ohio-based interventional pain company developing the micropellet.

With more than five million people in the U.S. affected by sciatica – one of the most common causes of back and leg pain – the Sollis micropellet can potentially provide patients with a pain-relief solution and an alternative to addictive opioid pain medications. Unfortunately, in many cases, currently available treatment options for the pain management of sciatica and other back pain have inadvertently led to opioid abuse.

“Having the opportunity to investigate new non-opioid treatments for sciatica and a range of pain conditions is directly aligned with the WVU Medicine Center for Integrative Pain Management’s mission to combat the opioid crisis in West Virginia and nationwide,” Richard Vaglienti, MD, principal investigator and director of the Center for Integrative Pain Management, said.

“Our doctors and researchers at the Rockefeller Neuroscience Institute continue to do amazing things that will help make all of our lives better,” President Gordon Gee said. “This kind of ground-breaking research would not be possible without the assistance of many people, including Gov. Jim Justice, Rep. David McKinley and Senators Shelley Moore Capito and Joe Manchin, all of whom have been fully supportive of these initiatives.”

In West Virginia, where the number of opioid-related deaths is on course to set a record for overdose deaths this year, the micropellet procedure – if successful – could one day be a game-changer.

“Knowing that even a single day of opioid usage is associated with a probability that the patient will be taking opioids a year later underscores the need for innovations like ours to impact the opioid crisis,” Gregory Fiore, MD, president and CEO of Sollis Therapeutics, said. “We are pleased to team up with the researchers at the WVU RNI and other sites nationwide.”

Additional patients are expected to participate in the study at WVU. To see if you or a family member might be eligible, please contact Angela Pugh by emailing ADPUGH@hsc.wvu.edu or calling 304.293.6780.

The West Virginia University Rockefeller Neuroscience Institute is a global leader in the discovery, development, and delivery of world-class research in human performance and brain health. It includes the clinical, research, and academic missions of the WVU Departments of Neurosurgery, Neurology, and Behavioral Medicine and Psychiatry, as well as several other academic departments across the university. The Institute spearheads efforts to develop innovative solutions for West Virginians and those across the world with neurological and psychiatric conditions ranging from Alzheimer’s to Parkinson’s; autism to stroke; and paralysis to chronic pain, addiction, and traumatic brain injury. For more information on the WVU Rockefeller Neuroscience Institute, visit wvumedicine.org/RNI



The Brushy Fork Event Center is ready to host everything from elegant weddings to corporate conferences. And when things don't go exactly as planned, the skilled staff is ready do what it takes to ensure every event is a success.

City ponders path forward as CVB relinquishes management of the Event Center at Brushy Fork

BUCKHANNON – Starting in April, a new entity will be managing the Event Center at Brushy Fork – but just who that is remains in flux after a lengthy discussion at Buckhannon City Council’s meeting Thursday explored several potential options, […]

Become a premium member to unlock immediate access to this story — and thousands more. Free trial available! Signing up is easy — just tap the button below.

Support Your Local Restaurants: The Links

By the Secret Chef If you believe life is too short to cook all the time (or maybe never 😉), The Links Restaurant located in the historic Buckhannon Country Club, now open to the public,


Basketball ‘Cats score season-low 38 points in loss to Salem

BUCKHANNON, W.Va. – The West Virginia Wesleyan men’s basketball team lost a non-conference matchup to Salem on Wednesday night 74-38. The Bobcats were held to their lowest point total of the season, shooting 17-64 (27%)

WVWC softball picked to win MEC South Divison

BRIDGEPORT, W.Va. – Frostburg State and West Virginia Wesleyan have been picked to win divisional championships during the 2023 Mountain East Conference softball season following a vote of the league’s head coaches. Frostburg State has been picked

Upshur County Sports Calendar

MONDAY (Feb. 6) Basketball TUESDAY (Feb. 7) Basketball Swimming WEDNESDAY (Feb. 8) Basketball Swimming THURSDAY (Feb. 9) Basketball Swimming FRIDAY (Feb. 10) Swimming Wrestling SATURDAY (Feb. 11) Acrobatics and Tumbling Basketball Wrestling SUNDAY (Feb. 12)